Frontlight ResearchEarly access
Trial site
The Cancer and Hematology Centers
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Melanoma2 trials
- Neuroendocrine tumours2 trials
- Chronic lymphocytic leukaemia1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Mantle cell lymphoma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Recruiting5 trials
- Active, not recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- IDEAYA Biosciences3 trials
- BeOne Medicines2 trials
- Exelixis1 trial
- Jazz Pharmaceuticals1 trial
- Ono Pharmaceutical Co., Ltd.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Neuroendocrine tumours2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Lung cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026